Aberrant expression of CD markers in AML in patients attending RIMS, Ranchi - An observational study.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 38736799.
- Also identified by DOI 10.4103/jfmpc.jfmpc_754_23 and PMC identifier 11086789.
- Licence recorded as CC BY-NC-SA.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Acute myeloid leukaemia (AML) is a tumour of hematopoietic progenitors caused by acquired oncogenic mutations that impede differentiation, leading to the accumulation of immature myeloid blasts in the marrow. Aberrant phenotype is a phenomenon in which lymphoid-associated and other myeloid lineage markers are expressed in myeloblasts or myeloid-associated markers are expressed in lymphoblasts. Diagnosed cases of AML were included in this study to study the aberrant expression using multiparametric flow cytometry. Out of a sample size of 50, 30 cases expressed aberrant CD markers. Male: Female ratio was 0.76. Majority of cases belonged to the age group >60 years of age. CD 7 was overall the most common aberrant CD marker. Immunophenotyping has a significant role in diagnosis and predicting prognosis of hematopoietic malignancies in the absence of more advanced diagnostic tools like cytogenetics.